1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Unresectable or Borderline Resectable Pancreatic Cancer: new trials by email Literature Review of Unresectable or Borderline Resectable Pancreatic Cancer trials Research Report on Unresectable or Borderline Resectable Pancreatic Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immune Checkpoint Inhibitor M7824 and the Immunocytokine M9241 in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Advanced Pancreas Cancer M7824, M9241, SBRT - Histologically or Cytologically Confirmed Pancreatic Cancer, Unresectable or Borderline Resectable Pancreatic Cancer | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 3 | 2021-06-15 | 2022-05-18 |
Digestive System Diseases (1) · Digestive System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Pancreatic Diseases (1)
NHS-IL12 immunocytokine (1) · Radiosurgery (1) · bintrafusp alfa protein, human (1)
National Cancer Institute (NCI) (1)
United States (1)